Treating Parkinson’s disease in the 21st century: Can stem cell transplantation compete?

The characteristic and selective degeneration of a unique population of cells—the nigrostriatal dopamine (DA) neurons—that occurs in Parkinson’s disease (PD) has made the condition an iconic target for cell replacement therapies. Indeed, transplantation of fetal ventral mesencephalic cells into the...

Descripción completa

Detalles Bibliográficos
Autores principales: Buttery, Philip C, Barker, Roger A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233918/
https://www.ncbi.nlm.nih.gov/pubmed/24610597
http://dx.doi.org/10.1002/cne.23577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233918/
https://www.ncbi.nlm.nih.gov/pubmed/24610597
http://dx.doi.org/10.1002/cne.23577

Ejemplares similares